SAMM - ETF AI Analysis

Top Page

Strategas Macro Momentum ETF (SAMM)

Rating:68Neutral

Price Target:―

SAMM’s rating reflects a portfolio tilted toward companies with strong financial performance and growth prospects, led by holdings like Medtronic, Parker Hannifin, and Amgen, which benefit from solid earnings, positive outlooks, and strategic initiatives. These strengths are partly offset by risks such as high valuations, leverage, and cash flow challenges in several holdings like GE Vernova and Eli Lilly, as well as mixed technical signals that suggest some stocks may be overbought. Overall, the main risk factor is exposure to companies where strong momentum and premium valuations increase sensitivity to market pullbacks.

Positive Factors

Strong Financial and Industrial Leaders

Several top holdings in financials and industrials have shown strong year-to-date gains, helping support the ETF’s overall performance.

Broad Sector Diversification

The fund spreads its investments across many sectors, including technology, health care, financials, and industrials, which can help reduce the impact of weakness in any single area.

Positive Recent Multi‑Month Performance

The ETF has delivered positive results over the past few months, indicating that its macro momentum approach has recently been working in investors’ favor.

Negative Factors

Higher Expense Ratio

The fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees instead of going to investors.

Heavy U.S. Concentration

With the vast majority of its holdings in U.S. companies, the ETF offers limited geographic diversification and remains highly tied to the U.S. market.

Mixed Performance Among Top Holdings

Some of the largest positions, including major banks and a leading technology company, have shown weak or negative year-to-date performance, which can drag on the fund’s returns.

SAMM vs. SPDR S&P 500 ETF (SPY)

AUM23.91M

RegionNorth America

Expense Ratio0.66%

Beta1.06

IssuerStrategas

Inception DateApr 03, 2024

Dividend Yield1%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume2,283

30 Day Avg. Volume3,674

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

33.75

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering32

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

SAMM Summary

The Strategas Macro Momentum ETF (SAMM) is an actively managed fund that follows a “macro momentum” theme instead of a fixed index. It looks across the whole U.S. stock market and different styles (large, small, growth, value) to invest where its managers see strong economic and market trends. The fund holds well-known companies like Apple and Bank of America, along with many others in technology, health care, and financials. Someone might invest for broad diversification with a tilt toward areas showing strong momentum. A key risk is that momentum can reverse quickly, so the ETF’s value can rise and fall sharply with changing market conditions.

How much will it cost me?The Strategas Macro Momentum ETF (SAMM) has an expense ratio of 0.66%, which means you’ll pay $6.60 per year for every $1,000 invested. This is higher than average because SAMM is actively managed, aiming to capitalize on macroeconomic trends and market momentum rather than simply tracking an index.

What would affect this ETF?SAMM's heavy exposure to the technology sector could benefit from innovation and growth in areas like AI and cloud computing, but it may face challenges if tech valuations decline due to rising interest rates or regulatory scrutiny. Its focus on U.S. markets means it could gain from domestic economic strength but may be vulnerable to downturns or geopolitical risks affecting North America.

SAMM Top 10 Holdings

SAMM is leaning hard into U.S. health care and industrials, and that’s where most of the action is. Parker Hannifin and GE Vernova are powering the fund higher with strong, steady momentum, while APA and Keysight add extra lift from energy and tech. On the flip side, Natera and Eli Lilly have been lagging, and Medtronic looks more stuck in neutral, tempering some of those gains. With all major holdings U.S.-based, this is very much a domestic, macro-momentum bet rather than a globally diversified story.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
MAR	Marriott International	4.62%	$1.10M	$94.33B	25.39%	62 Neutral
NTRA	Natera	4.54%	$1.08M	$29.81B	30.69%	73 Outperform
PH	Parker Hannifin	4.47%	$1.07M	$125.90B	53.26%	79 Outperform
AMGN	Amgen	4.05%	$966.91K	$204.70B	23.68%	77 Outperform
MDT	Medtronic	3.84%	$916.96K	$126.27B	7.69%	80 Outperform
APA	APA	3.79%	$904.71K	$10.15B	27.51%	73 Outperform
KEYS	Keysight Technologies	3.77%	$901.39K	$41.14B	38.81%	77 Outperform
GEV	GE Vernova Inc.	3.76%	$898.04K	$220.35B	153.24%	69 Neutral
UAL	United Airlines Holdings	3.69%	$881.17K	$37.82B	17.87%	74 Outperform
LLY	Eli Lilly & Co	3.64%	$870.76K	$962.75B	15.55%	72 Outperform

SAMM Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

30.69

Positive

100DMA

30.00

Positive

200DMA

28.41

Positive

Market Momentum

MACD

0.09

Positive

RSI

53.43

Neutral

STOCH

62.69

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SAMM, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 30.95, equal to the 50-day MA of 30.69, and equal to the 200-day MA of 28.41, indicating a bullish trend. The MACD of 0.09 indicates Positive momentum. The RSI at 53.43 is Neutral, neither overbought nor oversold. The STOCH value of 62.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SAMM.

SAMM Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
SAMM	―	―	$23.91M	0.66%	68 Neutral
BAMD	―	―	$99.66M	0.89%	69 Neutral
SOVF	―	―	$97.20M	0.75%	69 Neutral
STNC	―	―	$94.75M	0.85%	71 Outperform
RFDA	―	―	$83.46M	0.52%	71 Outperform
VAMO	―	―	$80.06M	0.65%	63 Neutral

Performance Comparison

SAMM

Strategas Macro Momentum ETF

31.13

4.36

16.29%

BAMD

Brookstone Dividend Stock ETF

―

SOVF

Sovereign's Capital Flourish Fund

―

STNC

Stance Equity ESG Large Cap Core ETF

―

RFDA

RiverFront Dynamic US Dividend Advantage ETF

―

VAMO

Cambria Value & Momentum ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents